Background: Myocardial perfusion imaging (MPI) is valuable for diagnosing coronary disease and assessing the risk of cardiac events. New technology based on semiconductors (Cadmium zinc telluride-CZT) enables reducing imaging time and improving image quality.
Methods: We retrospectively identified 57 patients who underwent MPI at Assuta using a CZT camera and invasive coronary angiography (ICA) within 60 days following nuclear testing without an intervening cardiac event, and without history of coronary disease.
Background: Previous studies have demonstrated accurate diagnosis of reduced dose myocardial perfusion imaging (MPI) using Cadmium-Zinc-Telluride (CZT) technology. We compared the diagnostic performances of very low stress-dose (<2 mSv) with standard-dose stress-first, quantitative MPI using a CZT camera.
Methods: Patients without known coronary artery- disease who underwent a stress-first Tc-99 m sestamibi CZT-MPI and invasive coronary angiography (ICA), and low-risk patients without ICA were included.